These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 12015747
1. A possible role for complement in the pathogenesis of chronic chagasic cardiomyopathy. Aiello VD, Reis MM, Benvenuti LA, Higuchi Mde L, Ramires JA, Halperin JA. J Pathol; 2002 Jun; 197(2):224-9. PubMed ID: 12015747 [Abstract] [Full Text] [Related]
2. Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods. Prochorec-Sobieszek M, Bilińska ZT, Grzybowski J, Mazurkiewicz L, Skwarek M, Walczak E, Michalak E, Cedro K, Chmielak Z, Debski A, Demkow M, Witkowski A, Wagner T, Ruzyłło W. Kardiol Pol; 2006 May; 64(5):479-87; discussion 488. PubMed ID: 16752331 [Abstract] [Full Text] [Related]
3. Patterns of myocardial fibrosis in idiopathic cardiomyopathies and chronic Chagasic cardiopathy. Rossi MA. Can J Cardiol; 1991 Sep; 7(7):287-94. PubMed ID: 1933634 [Abstract] [Full Text] [Related]
4. Regulation of complement membrane attack complex formation in myocardial infarction. Väkevä A, Laurila P, Meri S. Am J Pathol; 1993 Jul; 143(1):65-75. PubMed ID: 7686345 [Abstract] [Full Text] [Related]
5. Immunohistological analysis of CD59 and membrane attack complex of complement in muscle in juvenile dermatomyositis. Gonçalves FG, Chimelli L, Sallum AM, Marie SK, Kiss MH, Ferriani VP. J Rheumatol; 2002 Jun; 29(6):1301-7. PubMed ID: 12064850 [Abstract] [Full Text] [Related]
6. Inflammatory dilated cardiomyopathy (DCMI). Maisch B, Richter A, Sandmöller A, Portig I, Pankuweit S, BMBF-Heart Failure Network. Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686 [Abstract] [Full Text] [Related]
7. Dynamic expression of the membrane attack complex (MAC) of the complement system in failing human myocardium. Oliveira GH, Brann CN, Becker K, Thohan V, Koerner MM, Loebe M, Noon GP, Torre-Amione G. Am J Cardiol; 2006 Jun 01; 97(11):1626-9. PubMed ID: 16728227 [Abstract] [Full Text] [Related]
8. Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy. Noutsias M, Pauschinger M, Schultheiss H, K hl U. Med Sci Monit; 2002 Jul 01; 8(7):CR478-87. PubMed ID: 12118194 [Abstract] [Full Text] [Related]
9. [Vector electrocardiographic findings in chronic Chagas cardiomyopathy]. Montenegro Valdovinos PC, de Micheli A, Reyes López PA. Arch Inst Cardiol Mex; 1998 Jul 01; 68(1):51-7. PubMed ID: 9656083 [Abstract] [Full Text] [Related]
10. Inflammation in dilated cardiomyopathy. Pankuweit S, Ruppert V, Maisch B. Herz; 2004 Dec 01; 29(8):788-93. PubMed ID: 15599676 [Abstract] [Full Text] [Related]
11. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy. Schäfer R, Abraham D, Paulus P, Blumer R, Grimm M, Wojta J, Aharinejad S. Circulation; 2003 Sep 30; 108(13):1585-91. PubMed ID: 12963640 [Abstract] [Full Text] [Related]
12. Antigenic stimulation in the simian model of HIV infection yields dilated cardiomyopathy through effects of TNFalpha. Yearley JH, Mansfield KG, Carville AA, Sokos GG, Xia D, Pearson CB, Shannon RP. AIDS; 2008 Mar 12; 22(5):585-94. PubMed ID: 18316999 [Abstract] [Full Text] [Related]
13. Prognostic role of myocardial tumor necrosis factor-alpha and terminal complement complex expression in patients with dilated cardiomyopathy. Zimmermann O, Kochs M, Zwaka TP, Bienek-Ziolkowski M, Höher M, Hombach V, Torzewski J. Eur J Heart Fail; 2007 Jan 12; 9(1):51-4. PubMed ID: 16730227 [Abstract] [Full Text] [Related]
14. CD59 efficiently protects human NT2-N neurons against complement-mediated damage. Pedersen ED, Aass HC, Rootwelt T, Fung M, Lambris JD, Mollnes TE. Scand J Immunol; 2007 Jan 12; 66(2-3):345-51. PubMed ID: 17635812 [Abstract] [Full Text] [Related]
15. The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy. Karch R, Neumann F, Ullrich R, Neumüller J, Podesser BK, Neumann M, Schreiner W. Cardiovasc Pathol; 2005 Jan 12; 14(3):135-44. PubMed ID: 15914298 [Abstract] [Full Text] [Related]
16. Complement activation in muscle fiber necrosis: demonstration of the membrane attack complex of complement in necrotic fibers. Engel AG, Biesecker G. Ann Neurol; 1982 Sep 12; 12(3):289-96. PubMed ID: 6753731 [Abstract] [Full Text] [Related]
17. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Caforio AL, Tona F, Bottaro S, Vinci A, Dequal G, Daliento L, Thiene G, Iliceto S. Autoimmunity; 2008 Feb 12; 41(1):35-45. PubMed ID: 18176863 [Abstract] [Full Text] [Related]
18. Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction. Väkevä A, Laurila P, Meri S. Immunology; 1993 Oct 12; 80(2):177-82. PubMed ID: 8262547 [Abstract] [Full Text] [Related]
19. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. Skurk C, Wittchen F, Suckau L, Witt H, Noutsias M, Fechner H, Schultheiss HP, Poller W. Eur Heart J; 2008 May 12; 29(9):1168-80. PubMed ID: 18390538 [Abstract] [Full Text] [Related]
20. Expression of monocyte chemoattractant protein-1 in idiopathic dilated cardiomyopathy. Kobayashi M, Nakamura K, Kusano KF, Nakamura Y, Ohta-Ogo K, Nagase S, Sakuragi S, Ohe T. Int J Cardiol; 2008 Jun 06; 126(3):427-9. PubMed ID: 17467829 [Abstract] [Full Text] [Related] Page: [Next] [New Search]